hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases
Status:
NOT_YET_RECRUITING
Trial end date:
2028-08-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and preliminary efficacy of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles hUC-MSC-sEV-001 nasal drops in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple system atrophy, Lewy body dementia, frontotemporal dementia, and amyotrophic lateral sclerosis.